Know Cancer

or
forgot password

Therapeutic Topic Use of Chamomilla Recutita in Phlebitis Due to Peripheral Intravenous Therapy


Phase 3
18 Years
N/A
Not Enrolling
Both
Phlebitis

Thank you

Trial Information

Therapeutic Topic Use of Chamomilla Recutita in Phlebitis Due to Peripheral Intravenous Therapy


The hypothesis adopted was that patients with phlebitis due to peripheral intravenous
infusion in anti-neoplasm chemotherapy, treated with a compress of Chamomilla recutita
infusion for 20 minutes three times per day, would present a shorter phlebitis regression
time in comparison with patients treated with a lukewarm water compress.


Inclusion Criteria:



- Subjects with cancer who had infusion phlebitis during the administration of
intravenous chemotherapy peripheral under hospitalization.

Exclusion Criteria:

- Report made by the subject of study, prior hypersensitivity reaction or presentation
during the research, adverse reaction to chamomile or any plant of the family
Asteraceae ou Compositae: margarida (Aster tripolium), crisântemo (Chrysanthemum
leucanthemum), artemísia or isopo santo (Artemísia vulgaris), carpineira or ambrósia
americana (Ambrosia artemisiifolia) and senécio (Senecio jacobaea L.);

- Prescription during the process of data collection, some kind of anti-inflammatory
with systemic or topical activity where it was located phlebitis, and, upon the
occurrence of bacterial phlebitis, had been prescribed topical or systemic antibiotic
therapy;

- Refusal of the subject to participate in the study, regardless of the time.

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Outcome Measure:

phlebitis regression time

Outcome Time Frame:

medium of 7 days

Safety Issue:

Yes

Principal Investigator

Paula ED Reis, RN, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Sao Paulo

Authority:

Brazil: Ethics Committee

Study ID:

USPRecutita-01

NCT ID:

NCT00989599

Start Date:

September 2004

Completion Date:

September 2008

Related Keywords:

  • Phlebitis
  • phlebitis
  • Chamomilla recutita
  • Catheterization peripheral
  • Phlebitis

Name

Location